“…Clearinghouses may also miss dissertation studies that show promising results, such as Dickinson (2019) and Akay (2013). Based on the combined criterion from each clearinghouse (see Table 4), AdPT meets the following criteria for EBTs: (a) tested manualized protocol where interrater reliability was achieved (r = .78r = .89; Dillman Taylor & Kottman, 2019;Kottman, 2009) and (b) three randomized control trials (Ashori & Shamsi, 2023;Meany-Walen et al, 2014;Mirzaie et al, 2019). By meeting these standards, AdPT could be evaluated at Level 3, Promising Treatment, for Title IV-E PSC (see Table 1); Level 4, Possibly Efficacious Treatment, for SCCAP (see Table 2); and Level 3, Promising Research Evidence, for CEBC (see Table 3); however, researchers are in the process of submitting additional AdPT evidence for review (T. Kottman, personal communication, 2021;T.…”